Short answer
Health Catalyst, Inc. (HCAT) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 fiscal 2026 results released for quarter ended September 30, 2026.
Health Catalyst, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 fiscal 2026 results released for quarter ended September 30, 2026
- Exhibit 99.1 contains Health Catalyst’s financial results and management commentary
- Investor focus: quarterly performance, outlook, and any changes to operating trends in the accompanying release
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $56.3M, down 26% YoY after Vitalware divestiture and DOS-to-Ignite migration headwinds
- Adjusted EBITDA $0.8M, down 94% YoY, signaling sharply weaker underlying profitability despite cost reductions
- GAAP net income $40.5M benefited from a $65.9M Vitalware sale gain, masking operating deterioration
- Vitalware sale generated $144.5M proceeds, enabling repayment of $164.0M debt and leaving no long-term debt
- FY2026 outlook reaffirmed: revenue $246M-$249M and Adjusted EBITDA $18M-$18.5M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Health Catalyst, Inc. 8-K filings
Get the next HCAT 8-K as it lands
Follow HCAT for push alerts, or ask the research agent what this filing means.